Pierre Denys

10PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Neurology and neuromuscular diseasesNeural engineeringSensory systemsTraditional Chinese medicine and treatments
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 25, 2024
Real-World Use of Intradetrusor Botulinum Toxin Injections: A Population-Based Study from France.

Alain Ruffion, Pierre Karam, Anne Forestier

|Jun 26, 2024
Concomitant Botulinum Toxin Injections for Neurogenic Detrusor Overactivity and Spasticity-A Retrospective Analysis of Practice and Safety.

Arnaud Leilaz, Charles Joussain, Pierre Denys

|Mar 07, 2024
How to define failure of intradetrusor injections of botulinum toxin A for neurogenic detrusor overactivity.

Camille Mailho, Benoit Peyronnet, Marianne De Seze

|Jun 27, 2023
Safety and Effectiveness of Repeated Botulinum Toxin A Intracavernosal Injections in Men with Erectile Dysfunction Unresponsive to Approved Pharmacological Treatments: Real-World Observational Data.

François Giuliano, Pierre Denys, Charles Joussain

|Nov 02, 2022
AbobotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity regardless of spinal cord injury or multiple sclerosis etiology: Pooled analysis of two phase III randomized studies (CONTENT1 and CONTENT2).

Pierre Denys, Juan Carlos Castaño Botero, Ricardo Luis Vita Nunes

|Sep 22, 2022
Acute Intravesical Capsaicin for the Study of TRPV1 in the Lower Urinary Tract: Clinical Relevance and Potential for Innovation.

Karl-Erik Andersson, Delphine Behr-Roussel, Pierre Denys

Pageof 2

Frequent Collaborators

2 joint publications

Claire Hentzen

2 joint publications

Rebecca Haddad

2 joint publications

Benoit Peyronnet

2 joint publications

Xavier Gamé